TRANSKRIP Plus Chemotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TRANSKRIP Plus Chemotherapy, covering 2025-05-29 to 2025-05-29. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer [Phase 3]